152 related articles for article (PubMed ID: 7104231)
21. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
22. INITIAL EXPERIENCE WITH THROMBOTEST.
MILLER AL; FARRER-BROWN G; PETHER J
J Clin Pathol; 1964 Mar; 17(2):182-4. PubMed ID: 14149946
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation.
Jennings I; Luddington RJ; Baglin T
J Clin Pathol; 1991 Nov; 44(11):950-3. PubMed ID: 1752987
[TBL] [Abstract][Full Text] [Related]
24. Questions and answers on prothrombin time standardisation in oral anticoagulant control.
Loeliger EA; Poller L; Samama M; Thomson JM; Van den Besselaar AM; Vermylen J; Verstraete M
Thromb Haemost; 1985 Aug; 54(2):515-7. PubMed ID: 4082086
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of action and monitoring of anticoagulants.
Hirsh J
Semin Thromb Hemost; 1986 Jan; 12(1):1-11. PubMed ID: 3961504
[No Abstract] [Full Text] [Related]
26. International Normalized Ratio (INR): an improved way to monitor oral anticoagulant therapy.
Oertel LB
Nurse Pract; 1995 Sep; 20(9):15-6, 21-2. PubMed ID: 7501312
[TBL] [Abstract][Full Text] [Related]
27. Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
Guglielmone HA; Vides MA
Ann Biol Clin (Paris); 1990; 48(8):547-50. PubMed ID: 2288441
[TBL] [Abstract][Full Text] [Related]
28. Progress in the control of oral anticoagulation.
Loeliger EA
Thromb Diath Haemorrh; 1972 Aug; 28(1):109-19. PubMed ID: 5074987
[No Abstract] [Full Text] [Related]
29. A clinical study monitoring low-intensity anticoagulant therapy with a standard-sensitivity thromboplastin.
Brophy MT; Fiore LD; Lau J; Headley E; Allen M; Deykin D
Arch Pathol Lab Med; 1993 Jun; 117(6):618-21. PubMed ID: 8503734
[TBL] [Abstract][Full Text] [Related]
30. Prospective double-blind clinical trial of bovine, human, and rabbit thromboplastins in monitoring long-term oral anticoagulation.
Boekhout-Mussert MJ; van der Kolk-Schaap PJ; Hermans J; Loeliger EA
Am J Clin Pathol; 1981 Mar; 75(3):297-303. PubMed ID: 7010990
[TBL] [Abstract][Full Text] [Related]
31. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
Nilsson CU; Strandberg K; Reinstrup P
Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
[TBL] [Abstract][Full Text] [Related]
32. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
Tripodi A; Breukink-Engbers WG; van den Besselaar AM
Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
[TBL] [Abstract][Full Text] [Related]
33. Oral anticoagulation thresholds.
Brummel KE; Paradis SG; Branda RF; Mann KG
Circulation; 2001 Nov; 104(19):2311-7. PubMed ID: 11696471
[TBL] [Abstract][Full Text] [Related]
34. [Oral anticoagulants treatment of thrombosis].
Matsuda T
Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1523-7. PubMed ID: 8537761
[No Abstract] [Full Text] [Related]
35. [Initiation of oral anticoagulant treatment: comparison between different dosage regimens of warfarin and phenprocoumon].
Kemkes-Matthes B; Matzdorff A; Heidt M; Winkler L; Bernardo A; Bernardo A
Hamostaseologie; 2002 May; 22(2):47-51. PubMed ID: 12193977
[TBL] [Abstract][Full Text] [Related]
36. [Control of oral anticoagulation. Current concepts].
Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
[TBL] [Abstract][Full Text] [Related]
37. [Influence of the protein induced by vitamin K absence on thrombotest and hepaplastintest in the patients treated with oral anticoagulant].
Murakami S; Muratani H; Kikuchi T; Fujimoto S; Hayashi T; Inai S; Imaoka S
Rinsho Byori; 1983 Jan; 31(1):105-9. PubMed ID: 6865023
[No Abstract] [Full Text] [Related]
38. [Peroral anticoagulant therapy--are the TT-values reliable?].
Eilertsen H; Asprang AF; Ulveland K; Nerdrum HJ
Tidsskr Nor Laegeforen; 1998 Apr; 118(11):1690-2. PubMed ID: 9621756
[TBL] [Abstract][Full Text] [Related]
39. Comparison of native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant prophylaxis.
Kornberg A; Francis CW; Pellegrini VD; Gabriel KR; Marder VJ
Circulation; 1993 Aug; 88(2):454-60. PubMed ID: 8339409
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of factor II and factor X as therapeutic markers in patients under chronic warfarin therapy.
Costa IM; Serralheiro AI; Rodrigues M; Alves G; Falcão AC
Biomed Pharmacother; 2010 Feb; 64(2):130-2. PubMed ID: 20045627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
